Form 4: Macrogenics Director Scott Thomas Jackson Acquires Stock Options and Restricted Stock Units

Director Scott Thomas Jackson of Macrogenics Inc. reports acquisition of stock options and restricted stock units.

Summary

• On May 21, 2024, Scott Thomas Jackson, a director of Macrogenics Inc. (MGNX), acquired 16,500 stock options with an exercise price of $4.26, expiring on May 21, 2034.
• Jackson also acquired 6,500 restricted stock units (RSUs) which will vest one year after the grant date or the day prior to the next annual meeting, if earlier.
• Each RSU represents a contingent right to receive one share of Macrogenics' common stock.
• The stock options vest in monthly increments over 12 months from the grant date.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard insider transaction disclosure. The acquisition of shares and options by a director can be seen as a positive sign, but it's not a guarantee of future performance.

Positives

• The acquisition of stock options and RSUs by a director signals confidence in the company's future performance.

Industry Context

Form 4 filings are standard disclosures required by the SEC to ensure transparency regarding insider transactions, allowing investors to monitor the actions of company insiders.

Stakeholder Impact

• Shareholders can monitor insider transactions to gain insights into management's perspective on the company's value.

Key Dates